Register for email alerts and news feeds:
This journal | BMJ Group
rss
British Journal of Ophthalmology 1997;81:778-784; doi:10.1136/bjo.81.9.778
Copyright © 1997 by the BMJ Publishing Group Ltd.
Br J Ophthalmol 1997;81:778-784 ( September )

Oral immunisation as a strategy for enhancing corneal allograft survival

Ding Ma, Jessamee Mellon, Jerry Y Niederkorn

Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, USA

Correspondence to: Jerry Y Niederkorn, Department of Ophthalmology, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75235-9057, USA.

Accepted for publication 18 March 1997

AIMS---To determine optimal conditions for enhancing corneal allograft survival through oral administration of donor specific corneal cells.
METHODS---A mouse model of penetrating keratoplasty was used to evaluate the efficacy and optimal conditions for preventing immunological rejection of corneal allografts. C3H corneal grafts were transplanted orthotopically to CB6F1 recipients and represented mismatches at the entire major histocompatibility complex (MHC) and multiple minor histocompatibility loci. Tissue cultured C3H corneal epithelial and endothelial cells were administered orally to CB6F1 mice before or shortly after the application of orthotopic C3H corneal allografts. Cultured C3H corneal cells were conjugated with the non-toxic B subunit of cholera toxin as a means of preferentially inducing oral tolerance.
RESULTS---Ten oral doses of donor cells administered before keratoplasty reduced the incidence of corneal graft rejection from 100% in untreated hosts to 54% in orally tolerised mice. Conjugation of cholera toxin to corneal cells significantly enhanced the efficacy of oral tolerance such that only 9% of the mice fed 10 doses of cholera toxin conjugated cells rejected their corneal grafts. Even a single oral inoculation of corneal cells conjugated to cholera toxin was able to reduce corneal graft rejection by 36%.
CONCLUSIONS---Oral administration of donor specific cells greatly enhances corneal graft survival. Use of cholera toxin adjuvant markedly enhances the efficacy of oral tolerance such that even a single oral dose of donor cells significantly reduces the incidence of rejection. The results support the clinical feasibility of this novel strategy for preventing immunological rejection of corneal transplants.

© 1997 by British Journal of Ophthalmology
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Oral administration of antigen in the treatment of eye disease
K A WILLIAMS
Br. J. Ophthalmol. 1997 81: 714-715. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Jie, Y, Pan, Z, Chen, Y, Wei, Y, Zhang, W, Wu, Y, Peng, H, Xu, L (2005). Non-specific tolerance induced by staphylococcal enterotoxin B in treating high risk corneal transplantation in rats. Br. J. Ophthalmol. 89: 364-368 [Abstract] [Full Text]  
  • Yamada, J., Maruyama, K., Sano, Y., Kinoshita, S., Murata, Y., Hamuro, J. (2004). Promotion of Corneal Allograft Survival by the Induction of Oxidative Macrophages. IOVS 45: 448-454 [Abstract] [Full Text]  
  • Pan, Z., Chen, Y., Zhang, W., Jie, Y., Li, N., Wu, Y. (2003). Rat Corneal Allograft Survival Prolonged by the Superantigen Staphylococcal Enterotoxin B. IOVS 44: 3346-3351 [Abstract] [Full Text]  
  • Qian, Y., Boisgerault, F., Benichou, G., Dana, M. R. (2001). Blockade of CD40-CD154 Costimulatory Pathway Promotes Survival of Allogeneic Corneal Transplants. IOVS 42: 987-994 [Abstract] [Full Text]  
  • Qian, Y., Dekaris, I., Yamagami, S., Dana, M. R. (2000). Topical Soluble Tumor Necrosis Factor Receptor Type I Suppresses Ocular Chemokine Gene Expression and Rejection of Allogeneic Corneal Transplants. Arch Ophthalmol 118: 1666-1671 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Ophthalmology Jobs

Ophthalmology Jobs

Show me all >>